Cancer Board Gathers: Grants and Closed Doors Await
Published Date: 8/8/2025
Notice
Summary
The National Cancer Advisory Board is meeting on September 4, 2025, both in person and online to discuss cancer research updates and review grant applications. This meeting affects researchers and organizations seeking funding, with some parts closed to protect private info. If you want to join or comment, get ready to show ID and act fast—this is your chance to be part of the cancer-fighting conversation!
Analyzed Economic Effects
2 provisions identified: 1 benefits, 0 costs, 1 mixed.
NCI Will Review Grant Applications
On September 4, 2025, the National Cancer Advisory Board will review and evaluate grant applications during a closed session from 2:20 p.m. to 4:00 p.m. This meeting affects researchers and organizations seeking NCI funding because grant applications and related discussions will be considered on that date at the NCI–Shady Grove campus in Rockville, MD.
Public Access, ID, and Comment Rules
The meeting on September 4, 2025 is open to the public from 9:00 a.m. to 2:20 p.m. and may be viewed live via NIH Videocast (http://videocast.nih.gov/). Visitors to the NCI–Shady Grove campus must show one form of identification (for example, a government-issued photo ID, driver's license, or passport), and anyone needing special assistance to view the virtual meeting should notify the listed Contact Person in advance. Any interested person may file written comments with the committee by sending a statement (including name, address, phone number, and affiliation) to the Contact Person.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11892 — Proposed Collection; 60-Day Comment Request; Specimen Resource Locator (National Cancer Institute)
The National Cancer Institute wants your thoughts on a new way to track and locate cancer research samples through their Specimen Resource Locator. This affects researchers and labs who use these samples, aiming to make finding and sharing easier without adding extra costs or delays. You’ve got 60 days to share your feedback and help shape this helpful tool!
2026-11390 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in July 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide who gets funding to advance science. Researchers applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-11367 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review at the NIH is holding several closed virtual meetings in July 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide who gets funding for exciting science projects. If you’re involved in cell biology, heart disease, mental health, or cancer research, these reviews could impact your funding timeline and opportunities.
2026-11357 — National Library of Medicine; Notice of Partially Closed Meeting
The National Library of Medicine’s Board of Regents will hold a virtual meeting on July 16, 2026, with some parts open to the public and others closed to protect private info and trade secrets. This meeting affects researchers and grant applicants, as grant reviews will happen behind closed doors. Anyone can watch the open sessions online and send comments up to 15 days before the meeting—no registration needed!
2026-11018 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late June and early July 2026 to review important grant applications. These meetings protect private info and trade secrets while deciding which scientific projects get funding. Researchers applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-10813 — Government-Owned Inventions; Availability for Licensing
The National Institutes of Health just announced a cool new antibody called 18H2 that helps scientists spot a key protein in immune cells that keep us healthy. This invention is ready for companies to license and turn into real products, speeding up research and treatments for autoimmune diseases. If you’re interested, now’s the time to reach out and get the details—money and timing depend on your licensing deal!
Previous / Next Documents
Previous: 2025-15077 — Self-Regulatory Organizations; Miami International Securities Exchange, LLC; Notice of Filing and Immediate Effectiveness of a Proposed Rule Change To Amend Exchange Rule 307, Position Limits, and Exchange Rule 309, Exercise Limits To Allow the Exchange To Increase the Position and Exercise Limits for iShares Bitcoin Trust ETF
MIAX is boosting the maximum number of iShares Bitcoin Trust ETF options traders can hold and exercise, raising the limits from 25,000 contracts to a higher level. This change helps traders who want to handle bigger Bitcoin ETF option positions starting right away. If you trade these options, get ready for more room to grow your moves and potentially your profits!
Next: 2025-15079 — Office of the Director, National Institutes of Health; Notice of Meeting
The National Institutes of Health (NIH) is holding a hybrid meeting for the Council of Councils on September 11-12, 2025. This meeting affects researchers and grant applicants, as it includes open sessions for program updates and a closed session to review grant applications confidentially. Anyone interested can join virtually or in person, with no direct money changes announced but important grant decisions happening behind the scenes.